Pharmacological hallmarks of allostery at the M4 muscarinic receptor elucidated through structure and dynamics
eLife · 2023
DOI: 10.7554/elife.83477 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2023. Verfasst von Ziva Vuckovic und 23 weiteren Autor:innen. Beteiligte Einrichtung: Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia. Hauptthemen laut MEDLINE: Receptor, Muscarinic M4, Receptors, Muscarinic. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NIGMS NIH HHS, National Health and Medical Research Council.
Abstract (Originalsprache)
Allosteric modulation of G protein-coupled receptors (GPCRs) is a major paradigm in drug discovery. Despite decades of research, a molecular-level understanding of the general principles that govern the myriad pharmacological effects exerted by GPCR allosteric modulators remains limited. The M 4 muscarinic acetylcholine receptor (M 4 mAChR) is a validated and clinically relevant allosteric drug target for several major psychiatric and cognitive disorders. In this study, we rigorously quantified the affinity, efficacy, and magnitude of modulation of two different positive allosteric modulators, LY2033298 (LY298) and VU0467154 (VU154), combined with the endogenous agonist acetylcholine (ACh) or the high-affinity agonist iperoxo (Ipx), at the human M 4 mAChR. By determining the cryo-electron microscopy structures of the M 4 mAChR, bound to a cognate G i1 protein and in complex with ACh, Ipx, LY298-Ipx, and VU154-Ipx, and applying molecular dynamics simulations, we determine key molecular mechanisms underlying allosteric pharmacology. In addition to delineating the contribution of spatially distinct binding sites on observed pharmacology, our findings also revealed a vital role for orthosteric and allosteric ligand–receptor–transducer complex stability, mediated by conformational dynamics between these sites, in the ultimate determination of affinity, efficacy, cooperativity, probe dependence, and species variability. There results provide a holistic framework for further GPCR mechanistic studies and can aid in the discovery and design of future allosteric drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia.
- Center for Computational Biology and Department of Molecular Biosciences, University of Kansas, Lawrence, United States.
- ARC Centre for Cryo-electron Microscopy of Membrane Proteins, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia.
- Department of Pharmacology, Warren Center for Neuroscience Drug Discovery and Department of Chemistry, Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, United States.
- The Centre for Translational Pharmacology, Advanced Research Centre (ARC), College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
- Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
ORCID-Profile: Emma T van der Westhuizen, Andrew Tobin, Arthur Christopoulos, David M Thal
Förderung
- Wellcome Trust
- NIGMS NIH HHS
- National Health and Medical Research Council
- Australian Research Council
- National Institutes of Health
- Takeda Science Foundation
- Japan Science and Technology Agency
Zitieren
APA
Vuckovic, Z., Wang, J., Pham, V., Mobbs, J. I., Belousoff, M. J., Bhattarai, A., Burger, W. A. C., Thompson, G., Yeasmin, M., Nawaratne, V., Leach, K., van der Westhuizen, E. T., Khajehali, E., Liang, Y. L., Glukhova, A., Wootten, D., Lindsley, C. W., Tobin, A., Sexton, P., …, & Thal, D. M. (2023). Pharmacological hallmarks of allostery at the M4 muscarinic receptor elucidated through structure and dynamics. eLife. https://doi.org/10.7554/elife.83477
Vancouver
Vuckovic Z, Wang J, Pham V, Mobbs JI, Belousoff MJ, Bhattarai A, et al. Pharmacological hallmarks of allostery at the M4 muscarinic receptor elucidated through structure and dynamics. eLife. 2023. doi:10.7554/elife.83477
BibTeX
@article{Vuckovic2023,
author = {Vuckovic, Ziva and Wang, Jinan and Pham, Vi and Mobbs, Jesse I and Belousoff, Matthew J and Bhattarai, Apurba and Burger, Wessel A C and Thompson, Geoff and Yeasmin, Mahmuda and Nawaratne, Vindhya and Leach, Katie and van der Westhuizen, Emma T and Khajehali, Elham and Liang, Yi-Lynn and Glukhova, Alisa and Wootten, Denise and Lindsley, Craig W and Tobin, Andrew and Sexton, Patrick and Danev, Radostin and Valant, Celine and Miao, Yinglong and Christopoulos, Arthur and Thal, David M},
title = {Pharmacological hallmarks of allostery at the M4 muscarinic receptor elucidated through structure and dynamics},
journal = {eLife},
year = {2023},
doi = {10.7554/elife.83477}
}
EUVIMED